E-cigarettes, Nicotine Inhaler, and Blood Vessel Function
NCT ID: NCT03072628
Last Updated: 2023-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2017-01-11
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-cigarettes and Blood Vessel Function
NCT02740595
E-Cigarettes and SNA
NCT02724241
Acute Effects of E-Cigarette Aerosol Inhalation
NCT03479203
Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users
NCT02792426
Investigation of the Effects of Electronic Cigarettes on Vascular Health
NCT03041493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nicotine: use e-cig with nicotine
One time exposure to e-cig with nicotine
e-cig with nicotine
use an e-cig with nicotine for 30 minutes
no nicotine: use e-cig without nicotine
One time exposure to e-cig without nicotine
e-cig without nicotine
use an e-cig without nicotine for 30 minutes
Nicotine inhaler: use a nictoine inhaler
One time exposure to nicotine inhaler
nicotine inhaler
use a nicotine inhaler for 30 minutes
Sham control
Use an empty e-cigarette
sham control
use an empty e-cigarette for 30 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-cig with nicotine
use an e-cig with nicotine for 30 minutes
e-cig without nicotine
use an e-cig without nicotine for 30 minutes
nicotine inhaler
use a nicotine inhaler for 30 minutes
sham control
use an empty e-cigarette for 30 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Respiratory disease
* Diabetes mellitus
21 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Holly R Middlekauff
Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCaliforniaLA
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-000743-AM-00008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.